Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$2.38 -1.24%
Market Cap
$33.1M
Price Target
Refer to Report
Volume
66.7K
52wk Range
$0.68 - $5.37
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.